TOLTAROX 50 MG/ML ORAL SUSPENSION FOR PIGS

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Buy It Now

Active ingredient:

TOLTRAZURIL

Available from:

Krka, d.d., Novo mesto

ATC code:

QP51AJ01

INN (International Name):

TOLTRAZURIL

Dosage:

50 Mg/Ml

Pharmaceutical form:

Oral Suspension

Prescription type:

POM

Therapeutic group:

Porcine

Therapeutic area:

Toltrazuril

Therapeutic indications:

Coccidiostats

Authorization status:

Authorised

Authorization date:

2010-09-24

Summary of Product characteristics

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Toltarox 50 mg/ml oral suspension for pigs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
1 ml of oral suspension contains:
ACTIVE SUBSTANCE:
Toltrazuril
50 mg
EXCIPIENTS:
Sodium benzoate (E211)
2.1 mg
Sodium propionate (E281)
2.1 mg
For the full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Oral suspension.
Thick white suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pigs (Piglet 3 – 5 days old).
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the prevention of clinical signs of coccidiosis in neonatal piglets (3 - 5 days) on farms with a confirmed history of
coccidiosis caused by _Isospora suis_.
4.3 CONTRAINDICATIONS
Do not use in cases of hypersensitivity to the active substance or to any of the excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
As with any antiparasiticide, frequent and repeated use of antiprotozoals from the same class may lead to the
development of resistance.
4.5 SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
None known.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
Wash any splashes from skin or eyes immediately with water.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 28/08/2015_
_CRN 7019462_
_page number: 1_
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
None known.
4.7 USE DURING PREGNANCY, LACTATION OR LAY
Not applicable.
4.8 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION
None known, e.g. there is no interaction in combination with iron supplementation.
4.9 AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE
For oral use.
Individual animal tre
                                
                                Read the complete document
                                
                            

Search alerts related to this product